 PHILADELPHIA, Oct. 05, 2022 GLOBE NEWSWIRE -- Century Therapeutics NASDAQ: IPSC, an innovative biotechnology company developing induced pluripotent stem cell iPSC-derived cell therapies in immuno-oncology, today announced that preclinical data from the Companys iPSC-based cell therapy platform will be presented in two posters at the Society for Immunotherapy of Cancer SITC 37th Annual Meeting, on November 8-12, 2022 in Boston, Massachusetts. 